The semaglutide pen is a GLP-1 receptor agonist used for weight management and type 2 diabetes treatment. Our pharmaceutical-grade product meets the highest purity standards for research applications.
This peptide works by mimicking the effects of natural GLP-1, helping to regulate blood sugar levels and promote satiety. The semaglutide pen formulation offers precise dosing and convenient administration for research purposes.
Our manufacturing facility produces semaglutide pen under strict quality control measures, ensuring batch-to-batch consistency. Each vial undergoes comprehensive analytical testing to verify purity and potency before release.
The semaglutide pen is supplied as lyophilized powder in sterile vials, ready for reconstitution. Our products are intended solely for laboratory research use and not for human consumption.